The Office of the Inspector General (OIG) for the U.S. Nuclear Regulatory Commission (NRC) announces the conclusion of an investigation that resulted in an NRC-contracted radiopharmaceutical company paying $350,000 to resolve False Claims Act allegations concerning its subsidiaries falsely obtaining NRC fee reductions. Consistent with the False Claims Act, a substantial portion of the settlement amount will be provided to the agency to compensate it for its loss of annual fees.
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock
()
or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Office of the Inspector General
U.S. Nuclear Regulatory Commission and
Defense Nuclear Facilities Safety Board
Defense Nuclear Facilities Safety Board